Patents by Inventor Jigar Mukundbhai Raval

Jigar Mukundbhai Raval has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of saroglitazar pharmaceutical salts
    Patent number: 10112898
    Abstract: The present invention relates to an improved process for the preparation of pyrroles derivatives having hypolipidemic and hypocholesteremic activities. In particular, the invention relates to an improved process for the preparation of 2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoate and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also relates to an improved process for the preparation of mesylate compound (A1).
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: October 30, 2018
    Assignee: Cadila Healthcare Limited
    Inventors: Shri Prakash Dhar Dwivedi, Ramesh Chandra Singh, Jagdish Maganlal Patel, Vikas Patel, Vishwadeepak Rama Pati Tripathi, Pranav Jitendra Gangwar, Jigar Mukundbhai Raval
  • Amorphous form of vilazodone hydrochloride and process for its preparation
    Patent number: 9708300
    Abstract: The present invention relates to an amorphous form of vilazodone hydrochloride and process for the preparation of amorphous form of vilazodone hydrochloride. The invention also relates to pharmaceutical compositions that include a therapeutically effective amount of the amorphous form of vilazodone hydrochloride and use of said compositions for the treatment of major depressive disorder (MDD).
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: July 18, 2017
    Assignee: Cadila Healthcare Limited
    Inventors: Shirprakash Dhar Dwivedi, Ramesh Chandra Singh, Jigar Mukundbhai Raval
  • IMPROVED PROCESS FOR THE PREPARATION OF PYRROLE DERIVATIVES
    Publication number: 20160194280
    Abstract: The present invention relates to an improved process for the preparation of pyrroles derivatives having hypolipidemic and hypocholesteremic activities. In particular, the invention relates to an improved process for the preparation of 2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoate and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also relates to an improved process for the preparation of mesylate compound (A1).
    Type: Application
    Filed: September 5, 2014
    Publication date: July 7, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Shri Prakash Dhar DWIVEDI, Ramesh Chandra SINGH, Jagdish Maganlal PATEL, Vikas PATEL, Vishwadeepak Rama Pati TRIPATHI, Pranav Jitendra GANGWAR, Jigar Mukundbhai RAVAL
  • Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
    Patent number: 9212166
    Abstract: The present invention provides crystalline form of intermediates of Formula 2A, The present invention also provides process for the preparation of dabigatran etexilate mesylate; polymorph of intermediates thereof; particularly processes for the preparation of crystalline form of intermediates. The present invention also relates to the use of crystalline intermediates for the preparation of dabigatran etexilate mesylate.
    Type: Grant
    Filed: January 21, 2013
    Date of Patent: December 15, 2015
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Ramesh Chandra Singh, Jigar Mukundbhai Raval
  • PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE MESYLATE AND POLYMORPHS OF INTERMEDIATES THEREOF
    Publication number: 20150011589
    Abstract: The present invention provides crystalline form of intermediates of Formula 2A, The present invention also provides process for the preparation of dabigatran etexilate mesylate; polymorph of intermediates thereof; particularly processes for the preparation of crystalline form of intermediates. The present invention also relates to the use of crystalline intermediates for the preparation of dabigatran etexilate mesylate.
    Type: Application
    Filed: January 21, 2013
    Publication date: January 8, 2015
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Shriprakash Dhar Dwivedi, Ramesh Chandra Singh, Jigar Mukundbhai Raval
  • AMORPHOUS FORM OF VILAZODONE HYDROCHLORIDE AND PROCESS FOR ITS PREPARATION
    Publication number: 20140057925
    Abstract: The present invention relates to an amorphous form of vilazodone hydrochloride and process for the preparation of amorphous form of vilazodone hydrochloride. The invention also relates to pharmaceutical compositions that include a therapeutically effective amount of the amorphous form of vilazodone hydrochloride and use of said compositions for the treatment of major depressive disorder (MDD).
    Type: Application
    Filed: March 16, 2012
    Publication date: February 27, 2014
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Shriprakash Dhar Dwived, Ramesh Chandra Singh, Jigar Mukundbhai Raval